DEA marijuana rescheduling hearings begin June 29 as policymakers weigh science, crime data, tax revenue, and industry impacts. The long-running effort to move marijuana from Schedule I to Schedule III of the Controlled Substances Act is finally entering a critical phase. But how are the marijuana rescheduling hearing going? After months of delays, legal challenges, and procedural disputes, federal hearings on cannabis rescheduling are scheduled to begin June 29, 2026, and, in theory, are expected to conclude by July 15. The hearings could play a major role in determining the future of federal marijuana policy and whether cannabis receives a classification more in line with its current medical use and legal status in dozens of states.

The process has already experienced significant setbacks. Earlier hearings were scheduled for January 2025 were postponed after disputes involving participant selection, allegations of improper communications, and appeals related to the administrative process. Those delays frustrated cannabis businesses, medical advocates, and investors who had hoped for quicker action. One of the biggest questions surrounding the hearings is whether they will include a fair and balanced group of participants. The DEA has opened the process to “interested persons” who can demonstrate they are affected by the proposed rule. Industry groups, medical professionals, researchers, state regulators, anti-legalization organizations, veterans advocates, and consumer groups have all sought participation. NORML, one of the nation’s oldest cannabis advocacy organizations, has argued cannabis consumers themselves should have a voice in the proceedings. Critics on both sides continue to debate whether the participant list fully reflects the broad range of stakeholders impacted by federal marijuana policy.

The current presidential administration appears to be pushing for a faster resolution than previous efforts. The Department of Justice has repeatedly described the new process as expedited, and federal officials have emphasized the need for a timely conclusion. The hearing schedule itself reflects the goal, with firm deadlines established for testimony and administrative review. Several legal analysts have noted the administration’s actions suggest a desire to move the issue forward rather than allow it to become trapped in years of procedural delays.

Another important issue is whether real-world crime data is being considered. Advocates for rescheduling frequently point to studies and state-level data showing legalization has not produced the dramatic increases in violent crime predicted by opponents. Others argue criminal justice impacts, including reduced marijuana arrests and lower burdens on courts and law enforcement, should be part of the federal discussion. While the DEA’s primary legal standard focuses on medical use, abuse potential, and scientific evidence, many stakeholders are expected to reference crime trends and public safety outcomes during testimony. State tax revenue is also expected to be part of the broader conversation. Legal cannabis markets have generated billions of dollars in state tax collections nationwide, funding education, public health programs, infrastructure projects, and social equity initiatives. While tax revenue itself is not one of the statutory factors used to determine scheduling status, supporters of reform argue the economic realities created by state legalization can no longer be ignored. The growing conflict between state-regulated markets and federal prohibition remains one of the strongest arguments for updating federal policy.

As the hearings begin, the outcome remains uncertain. What is clear is the process has become far more than a debate about medical science. It now encompasses criminal justice reform, state sovereignty, economic development, tax policy, and the growing disconnect between federal law and the realities of cannabis legalization across much of America. The hearings scheduled for this summer may ultimately determine whether federal marijuana policy finally catches up with public opinion and state-level reforms.

The Fresh Toast is a daily lifestyle platform with a side of cannabis. For more information, visit www.thefreshtoast.com.

The Fresh Toast